Product Information

AMLODIPINE-VALSARTAN 5-320 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3525 per EA under NDC 33342028107. Its NADAC has been published 77 times since Mar 5, 2025.

FDA first approved this application on Oct 11, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN 5-320 MG

amlodipine and valsartan
$0.3525per EA

Strength

5; 320 mg/1; mg/1

NDC

33342028107

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207292

FDA Approved

10/11/2024

TE Code

AB

On Market Since

10/16/2024

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN 5-320 MG has been published 77 times since Mar 5, 2025, and over the history we have for it it has declined 38.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3525 per EA
All-time high$0.5890 (May 14, 2025)
All-time low$0.3525 (Aug 19, 2026)
52-week high$0.5510
52-week low$0.3525
Median price$0.5334
Average price$0.5309
Largest weekly change-14.1% (Jul 22, 2026)
Weeks tracked77
Tracking sinceMar 5, 2025

Price History

1W

-6.6%

1M

-6.6%

3M

-30.7%

6M

-33.7%

1Y

-36.0%

3Y

N/A

5Y

N/A

All

-38.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN 5-320 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-320 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.3525 per EA (NDC 33342028107), effective Aug 19, 2026.

How has the price of AMLODIPINE-VALSARTAN 5-320 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has declined 38.2%. It has been tracked across 77 weekly CMS publications since Mar 5, 2025.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-320 MG?

Since Mar 5, 2025, the NADAC for AMLODIPINE-VALSARTAN 5-320 MG has ranged from a low of $0.3525 (Aug 19, 2026) to a high of $0.5890 (May 14, 2025), with a median of $0.5334 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-320 MG?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-VALSARTAN 5-320 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-VALSARTAN 5-320 MG?

AMLODIPINE-VALSARTAN 5-320 MG (NDC 33342028107) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.